๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Intra-individual variability in genetic and environmental models of attention-deficit/hyperactivity disorder

โœ Scribed by G.M.L. Perry; T. Sagvolden; S.V. Faraone


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
216 KB
Volume
9999B
Category
Article
ISSN
1552-4841

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Toward guidelines for pedigree selection
โœ Stephen V. Faraone; Joseph Biederman; Michael C. Monuteaux ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 56 KB ๐Ÿ‘ 2 views

Converging evidence from family, twin, and adoption studies points to a substantial genetic component of the etiology of attention deficit hyperactivity disorder (ADHD). These data about ADHD have motivated molecular genetic studies of the disorder, which have produced intriguing but somewhat confli

Clinical utility of the test of variable
โœ Gordon B. Forbes ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 115 KB ๐Ÿ‘ 2 views

Ability of the Test of Variables of Attention (TOVA) to distinguish between referred children with attention-deficit/hyperactivity disorder (ADHD) and other (OTHER) clinical diagnoses were studied. The ADHD group differed from the OTHER group on TOVA variables and most measures from the Revised Conn

Pharmacology of methylphenidate, ampheta
โœ Kennerly S. Patrick; John S. Markowitz ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 239 KB ๐Ÿ‘ 1 views

Racemic methylphenidate remains the drug of choice for attention-deยฎcit hyperactivity disorder (ADHD). Methylphenidate appears to produce psychostimulation by inhibiting the presynaptic uptake of impulse-released dopamine. The absolute bioavailability of methylphenidate in humans is quite low and va